Trial intelligence / Profile preview

Topical mepivacaine vs lidocaine with total intravenous anesthesia for shared airway surgery in children

ChiCTR2200062233Phase 4Not yet recruiting

Sponsor
Shanghai Children's Medical Center
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of mepivacaine, lidocaine and propofol in arrhythmogenic cardiomyopathy (ACM) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Amount of propofol. Planned start Aug 2022; status: not yet recruiting.

02

Drugs

mepivacainelidocainepropofol
03

Conditions

arrhythmogenic cardiomyopathy (ACM)

Beyond the preview

Go deeper on ChiCTR2200062233.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200062233.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call